ITGAM and cancer: As a complementary approach to CKO, we carried out an add-back experiment by co-injecting cancer cells into the KO mice (the recipients) with myeloid cells (CD11b+) from four groups of lungs: WT or KO with CTX or control pre-treatment (diagrammed in Figure 3b).